Noticias y vídeos - AMARIN CORP.

Thinking about buying stock in Oncolytics Biotech, Amarin Corporation, Biophytis, bluebird bio, or VERSES AI? PR Newswire NEW YORK, July 19, 2023 NEW YORK , July 19, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ONCY, AMRN, BPTS, BLUE, and VRSSF. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ONCY:...

Sarissa Capital Management LP today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Amarin shareholders have sent a loud and clear message repudiating the incumbent Amarin board. Sarissa thanks fellow shareholders for their support in a resounding victory against the Amarin board. Our estimate is that up to nearly 80% of shareholder votes were in support of Sarissa. As Amarin’s largest shareholder, we are grateful for the opportunity to remake Amarin for the...

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa is appalled at this latest act of betrayal of the shareholders by the Amarin board. Sarissa has been urging the Amarin board to release the results of the proxy contest for several days. The board, however, has steadfastly refused, leaving Amarin shareholders to twist in the wind. Now we know why the board has opted to sit on this powder keg of information....

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa urges Amarin shareholders to vote “FOR” change TODAY to remake the Amarin board for shareholders at our upcoming meeting. Given the voting logistics for the meeting, votes must be submitted TODAY in order to be received in time to be counted for tomorrow’s formal deadline. IF YOU ALREADY VOTED “FOR” ALL PROPOSALS AND SUBMITTED YOUR PROXY CARD,...

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa urges Amarin shareholders to vote “FOR” necessary change at our upcoming shareholder meeting. The outcome of this meeting will significantly affect the future of Amarin. The decision is one of maintaining the status quo with the current regime which has overseen a tremendous destruction of shareholder value or remaking Amarin for the benefit of...

Sarissa Capital Management LP (“Sarissa”) today issued a presentation detailing the dire need for change at Amarin Corporation plc (NASDAQ: AMRN) accessible at the link below: Presentation: https://freeamarin.com/wp-content/pdfs/vote-for-change.pdf Amarin shareholders face an important decision at our upcoming shareholder meeting. Amarin has a uniquely valuable asset in Vascepa/Vazkepa, a drug that can meaningfully reduce cardiovascular events in patients and save significant resources for...

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa Capital is outraged but not surprised by Amarin’s repeated false statements intended to mislead shareholders and switch votes away from Sarissa. Amarin has made these false statements throughout this proxy contest, including in its evaluation of the company’s progress and its own performance, in its characterizations of the board’s interactions with...

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa Capital believes that today’s Amarin webcast was yet again tone-deaf to shareholders and another display by management of a lack of accountability for its poor performance. Today’s webcast was a missed opportunity for Amarin leadership to truly engage with frustrated shareholders, take accountability for their numerous missteps and embrace the benefits...

Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin Corporation plc (NASDAQ: AMRN): Sarissa launches website for shareholders. For Sarissa’s presentation, how to vote, and future communications, please visit Sarissa’s website address below. Website: www.freeamarin.com Presentation: https://freeamarin.com/wp-content/pdfs/presentation-slides-opt.pdf How to vote: https://freeamarin.com/wp-content/pdfs/how-to-vote.pdf Vote the BLUE proxy card “ FOR ”...

Sarissa Capital Management LP (“Sarissa”) today issued the following letter to fellow shareholders of Amarin Corporation plc (NASDAQ: AMRN): Dear Fellow Amarin Shareholders: Amarin shareholders face an important decision at our upcoming shareholder meeting. Amarin has an incredibly valuable asset in Vascepa/Vazkepa, a drug that can meaningfully reduce cardiovascular events in patients and save significant resources for health systems worldwide. The value of Vascepa, however, has been wasted...

Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin Corporation plc (NASDAQ: AMRN): At the last shareholder meeting, the shareholders, the owners of the company, loudly expressed their lack of faith in the board and management. Sarissa sought to place shareholder representatives on the board and engaged with the company in what turned out to be months of simply lip service by the board, led by its Chairman Per Wold-Olsen. Despite Sarissa having a track...

Sarissa Capital Management LP (“Sarissa”) today made the following statement regarding its ongoing discussions with Amarin Corporation plc (NASDAQ: AMRN) regarding board representation: Amarin’s board seems to be trying to outdo the misguided leadership of the Roman Emperor Nero who played his lyre while Rome was engulfed in flames. Their “imperial” attitude and inaction is the problem. We, along with all shareholders, must try to fix the company. This year alone, Amarin shareholders...

Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin Corporation plc (NASDAQ: AMRN) regarding how it intends to vote at the upcoming Amarin annual meeting and the reasons therefor: Sarissa is a sophisticated, institutional investor with a long history of shareholder value creation in healthcare companies, including in the cardiovascular space, such as The Medicines Company. As Amarin's largest shareholder, we are frustrated by the performance of Amarin’s...

Thinking about buying stock in Amarin, Iamgold, Amcor, Freshworks, or Sesen Bio? PR Newswire NEW YORK, May 4, 2022 NEW YORK , May 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMRN, IAG, AMCR, FRSH, and SESN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. AMRN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=AMRN&prnumber=050420225 IAG:...

Thinking about buying stock in Verastem, AT&T, Athersys, Beyond Meat, or Amarin? PR Newswire NEW YORK, April 12, 2022 NEW YORK , April 12, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VSTM, T, ATHX, BYND, and AMRN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. VSTM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=VSTM&prnumber=041220222 T:...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation PLC, of Class Action Lawsuit and Upcoming Deadline - AMRN PR Newswire NEW YORK, Dec. 21, 2021 NEW YORK , Dec. 21, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Amarin Corporation PLC ("Amarin" or the "Company") (NASDAQ: AMRN) and certain of its officers. The class action, filed in the United States District Court for the District of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021 - AMRN PR Newswire NEW YORK, Dec. 21, 2021 NEW YORK , Dec. 21, 2021 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Amarin Corporation Plc ("Amarin") (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021 . You are...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021 - AMRN PR Newswire NEW YORK, Dec. 15, 2021 NEW YORK , Dec. 15, 2021 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Amarin Corporation Plc ("Amarin") (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021 . You are...

ROSEN, A LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 23 Deadline in Securities Class Action - AMRN PR Newswire NEW YORK, Dec. 14, 2021 NEW YORK , Dec. 14, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021 , inclusive (the "Class Period") of the important...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation PLC, of Class Action Lawsuit and Upcoming Deadline - AMRN PR Newswire NEW YORK, Dec. 13, 2021 NEW YORK , Dec. 13, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Amarin Corporation PLC ("Amarin" or the "Company") (NASDAQ: AMRN) and certain of its officers. The class action, filed in the United States District Court for the District of...